Open AccessBaseline Corticosteroid Use and Corticosteroid-Free Clinical Remission in Crohn’s Disease Patients Treated With Certolizumab Pegol in the PRECiSE 2 Trial
Author(s) -
William J. Sandborn,
Brian G. Feagan,
Scott Lee,
Stephen B. Hanauer
Publication year - 2012
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1097/00054725-201212001-00058
Subject(s) - certolizumab pegol , medicine , corticosteroid , placebo , population , discontinuation , crohn's disease , randomized controlled trial , surgery , infliximab , disease , pathology , alternative medicine , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom